CNBC
US · 3 hrs ago
AI scored
Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals
78Accuracy
centreBias
0Ratings
💬 0Comments
AI Analysis
Accuracy 78/100
Partisan intensity 15/100
ObjectivePartisan
Centre / Neutral ✓ Fair headline
Novo Nordisk's CEO Mike Doustdar states that the pharmaceutical company is actively pursuing acquisition and partnership deals at an increased pace. This reflects the company's strategy to expand beyond its flagship weight-loss and diabetes drugs like Ozempic and Wegovy.
Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals
Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!